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The role of the msaABCR operon in
implant-associated chronic osteomyelitis in
Staphylococcus aureus USA300 LAC
Gyan S. Sahukhal1* , Michelle Tucci2, Hamed Benghuzzi2, Gerri Wilson2 and Mohamed O. Elasri1
Abstract
Background: The msaABCR operon regulates several staphylococcal phenotypes such as biofilm formation, capsule
production, protease production, pigmentation, antibiotic resistance, and persister cells formation. The msaABCR operon is
required for maintaining the cell wall integrity via affecting peptidoglycan cross-linking. The msaABCR operon also plays a
role in oxidative stress defense mechanism, which is required to facilitate persistent and recurrent staphylococcal infections.
Staphylococcus aureus is the most frequent cause of chronic implant-associated osteomyelitis (OM). The CA-MRSA USA300
strains are predominant in the United States and cause severe infections, including bone and joint infections.
Results: The USA300 LAC strain caused significant bone damage, as evidenced by the presence of severe bone
necrosis with multiple foci of sequestra and large numbers of multinucleated osteoclasts. Intraosseous survival and
biofilm formation on the K-wires by USA300 LAC strains was pronounced. However, the msaABCR deletion mutant was
attenuated. We observed minimal bone necrosis, with no evidence of intramedullary abscess and/or fibrosis, along
reduced intraosseous bacterial population and significantly less biofilm formation on the K-wires by the msaABCR
mutant. microCT analysis of infected bone showed significant bone loss and damage in the USA300 LAC and
complemented strain, whereas the msaABCR mutant’s effect was reduced. In addition, we observed increased
osteoblasts response and new bone formation around the K-wires in the bone infected by the msaABCR mutant.
Whole-cell proteomics analysis of msaABCR mutant cells showed significant downregulation of proteins, cell adhesion
factors, and virulence factors that interact with osteoblasts and are associated with chronic OM caused by S. aureus.
Conclusion: This study showed that deletion of msaABCR operon in USA300 LAC strain lead to defective biofilm in K-
wire implants, decreased intraosseous survival, and reduced cortical bone destruction. Thus, msaABCR plays a role in
implant-associated chronic osteomyelitis by regulating extracellular proteases, cell adhesions factors and virulence
factors. However additional studies are required to further define the contribution of msaABCR-regulated molecules in
osteomyelitis pathogenesis.
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Background
Staphylococcus aureus is the most common pathogen caus-
ing chronic infections in humans [1–3], and osteomyelitis
(OM) is one of the primary chronic infections caused by
this pathogen [4–7]. According to Gerber et al. [2] and
Weichert et al. [8], approximately 2.5 of every 1000 hospital
admitted children has staphylococcal OM [2, 8]. Among
adults, staphylococcal OM frequently complicates open
fractures and soft-tissue infections [6, 9]. In addition, noso-
comial infections by S. aureus in immunocompromised pa-
tients, severely debilitated patients, and patients with
indwelling medical devices are on the rise [10–12]. The in-
creasing use of surgically implanted orthopedic medical de-
vices has led to an increased risk of implant-associated OM
infection [6, 13, 14]. Implant-associated OM is a chronic
and deep bone infection, and studies have shown that S.
aureus is the most common causative pathogen, accounting
for 20–30% of chronic OM cases associated with fracture
fixation and prosthetic joint replacement [15–18]. Accord-
ing to Darouiche [19], 600, 000 artificial joint replacements
and 2 million fracture fixation devices are implanted each
year in the U.S., resulting in > 110,000 infections [19]. Fur-
thermore, 65% of military injuries are orthopedic, with an
infection rate of 50%, and S. aureus is the most prevalent
pathogen in these infections [19]. The community-
associated, methicillin-resistant S. aureus (CA-MRSA)
strains are emerging as leading pathogens causing the se-
vere sepsis associated with acute OM [5, 7, 8, 20]. The CA-
MRSA USA300 clone is the predominant strain in the
United States and has been responsible for severe infec-
tions, including bone and joint infections [21–24].
Treatment of OM infections by S. aureus is complex and
involves one or more surgical debridement, implant
removal, and prolonged antimicrobial therapy. The ability
of S. aureus to form biofilm, small colony variants, and
persister cells inside osteoblasts contributes to treatment
recalcitrance [25–28]. Previous retrospective studies by
Marculescu et al. [29] and Lee et al. [30] both found that
the treatment failure rate for implant-associated OM is high
(58.2 and 41.8%, respectively). Thus, despite all the sophisti-
cated procedures and efforts to maintain high sterility stan-
dards to prevent onset of implant-associated OM infection,
it is still a significant challenge in the clinic [11, 12].
The msaABCR operon is a four-gene operon that reg-
ulates several virulence factors (proteases as well as fac-
tors involved in pigmentation, toxin production, and
capsule production), biofilm formation, persister cell for-
mation, oxidative stress response, and antibiotic suscep-
tibility in S. aureus [31–37]. We also showed that
msaABCR deletion mutants are not defective in growth
[33]. Previously, we showed that msaABCR mutants are
defective in biofilm formation due to increased produc-
tion of extracellular proteases in vitro [31]. MsaB is the
only protein expressed from this operon, and we have
shown that MsaB is the DNA-binding protein that directly
regulates the virulence factor for processes such as capsule
production [32, 34, 35]. A separate study by Caballero et al.
[38] showed that MsaB is an RNA chaperone that positively
and negatively modulates the expression of its target pro-
teins, which are involved in carbohydrate metabolism, ribo-
nucleotide metabolism, and the stress response, and these
include several other virulence factors [38]. Previously, we
also showed that the msaABCR operon regulates the ex-
pression of 238 genes that are involved in metabolism,
pathogenesis, transport, signal transduction, and stress
response [33]. The primary objective of this study is to test
the contribution of the global modulator msaABCR operon
in pathogenesis in vivo using implant-associated OM in a
SD rat model. In this model of implant associated osteo-
myelitis, we used K-wires coated with S. aureus strains to
implant transcortically through the tibial metaphysis as pre-
viously described to mimic clinical OM infection [39, 40].
We used community-associated methicillin-resistant S. aur-
eus strain USA300 LAC and its isogenic msaABCR mutant.
Results
The chronic implant-associated OM model
Sprague Dawley rats were used to study the role of the
msaABCR operon in the pathogenesis of chronic implant-
associated OM and intraosseous bacterial survival. Rats
were infected with a clinical isolate of USA300 LAC due to
its prevalence in community-associated invasive infections.
For induction of chronic implant-associated OM, K-wires
were first colonized with the test strains (USA300 LAC,
msaABCR mutant, and msaABCR complementation) and
implanted transcortically through the bone metaphysis
(Fig. 1a). To ensure that the bacterial cells attach the K-
wires at the same rate, the bacterial CFUs were enumerated
from the colonized K-wires (six K-wires per bacterial
strain). The average number of bacterial CFUs colonized in
the K-wires (1.25X107 CFUs) was similar in all test strains
and were not statistically different (Fig. 1b). Also, to ensure
an equivalent number of bacterial inoculums in the bone
prior to infection process and during surgery, the infected
K-wires with test strains (3 animals per group) were
inserted in the rat bone. The rats were humanely eutha-
nized immediately to harvest the bone and K-wire samples
to enumerate the bacterial CFUs. The average bacterial load
retained in the bone (6.09X105 CFUs) and on the K-wires
(1.45X104 CFUs) after the surgical procedure were not sta-
tistically different from each other (Fig. 1b).
Intraosseous bacterial burden and biofilm formation
The intraosseous bacterial burden in the infected bone
was assessed after each infection period as described in
the methods (Fig. 2a, b, and c). The K-wires were carefully
excised from the infected bone samples and processed for
microbial counting to quantify biofilm formation in the K-
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wires (Fig. 2d, e, and f). The results showed that the
intraosseous bacterial burden in the infected bone and bio-
film formation in the k-wires were significantly less in the
msaABCR mutant group compared to the USA300 LAC
and the complementation group during all post-infection
periods (Fig. 2). These findings showed that the msaABCR
mutant is defective in intraosseous survival and biofilm for-
mation on K-wires in the implant-associated OM rat model
(Fig. 2). These observations correlate with our previous
findings showing a defective biofilm phenotype for the
msaABCR mutant under in vitro conditions [31].
Dissemination of Staphylococcus to different organs
To study bacterial survival in blood and dissemination to
different vital organs (heart, liver, spleen, lungs, kidney,
and liver), microbial counts were obtained from the post-
mortem blood and organ samples. Our results showed
that the bacterial CFUs in blood, heart, and spleen sam-
ples recovered from the animals infected with the
msaABCR mutant were less compared to USA300 LAC
and complementation strains during all post-infection pe-
riods, but the differences were not statistically significant
(Fig. 3a, b, and c). However, in the liver, kidney, and lung
samples, all the animals infected with all three test strains
showed similar numbers of bacterial CFUs throughout the
infection periods (Additional file 1: Fig. S1).
Analysis of bone damage by microCT
To further delineate the role of the msaABCR operon in
the pathogenesis of OM, the infected bones harvested
after each infection period were analyzed by microCT.
At day 4 post-infection, no significant bone damage was
observed in the reconstructed 3D microCT images of in-
fected bone by all the test strains (Fig. 4a and b). However,
we observed significant cortical bone damage around the
K-wire insertion area in bone infected with the USA300
LAC and complementation strains after 8- and 15- days
post-infection periods relative to the bone infected with
the msaABCR mutant strains (Fig. 4c-f). During the
process of harvesting K-wires before microCT scanning of
the msaABCR mutant infected bone (Day 8), a small piece
of bone was missing near the infection area, as evident in
the 3D image (Fig. 4c). Morphometric analysis showed no
significant changes in bone microarchitectural patterns in
the infected bones by all test strains after 4- and 8- days
post-infection (Additional file 2: Fig. S2 and Add-
itional file 3: Fig. S3). However, the significant changes the
bone microarchitectural patterns in the bone infected with
Fig. 1 Examination of K-wire localization and microbial load in bone and K-wires after surgery. The K-wire was inserted in the tibia of Sprague
Dawley rats surgically and examined by X-ray to assure its positioning (a). The microbial load before K-wire implantation and after surgery (b). The
microbial load was estimated for both K-wires and bone (n = 3) to ensure an equal starting microbial load (USA300 LAC, msaABCR mutant, and
complementation strains) prior to the infection process. Error bars indicate standard errors of the means. The differences in the numbers of
microbial CFUs between the test strains were not statistically significant when analyzed by one-way ANOVA followed a post-hoc Tukey test
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the USA300 LAC and complementation strains were evi-
dent after 15 days post-infection. We observed significantly
altered BV/TV, BS/BV, Tb.pf, Tb. Sp, Tb. Th, and Tb. N in
the bone samples infected with the USA300 LAC and
complementation strains, thus revealing compromised
trabecular microarchitecture and massive bone destruc-
tion by these strains relative to the msaABCR mutant
strains (Fig. 5).
Histopathological analysis of infected bone
The infected bone samples were fixed, sectioned, and
stained with H&E, and histopathological scores were
assessed [41] , as shown in Table 1.
Day 4 post-infection
Bone samples from the sham group showed a minimal
presence of intraosseous inflammatory cells and intraoss-
eous fibrosis, with no evidence of any periosteal abscess or
bone necrosis (Fig. 6a). Bone infected with the USA300
LAC strain showed severe intraosseous inflammation and
evidence of intramedullary abscess. We also observed the
presence of osteoclast activity in bone infected with
USA300 LAC strain (Fig. 6a). Bone infected by the
msaABCR mutant showed a minimal-to-mild intraosseous
inflammatory response with intramedullary abscess (Fig. 6a).
Bone infected with complementation strain showed severe
intraosseous inflammation and evidence of intramedullary
abscess (Fig. 6a). Overall, bone harvested from the sham
group received a total histopathological score of 2, whereas
bone infected by USA300 LAC, msaABCR mutant, and
complementation strains received total histopathological
scores of 8, 7, and 8, respectively (Fig. 6b).
Day 8 post-infection
We observed increased osteoblast response, with a min-
imal presence of intraosseous inflammatory cells, and with
no evidence of intramedullary abscess, intraosseous fibro-
sis, periosteal abscess, and bone necrosis in the bone in-
fected with sham group (Fig. 7a). The presence of
moderate-to-severe intraosseous and periosteum inflam-
mation with evidence of intramedullary abscess as well as
bone necrosis with multiple foci of sequestra are the hall-
mark features of bone infected with the USA300 LAC and
complementation strains (Fig. 7a). An increased osteoblast
response lining the site adjacent to the K-wire was also
observed in the bone infected with the msaABCR mutant,
but not observed in the bones infected with USA300 LAC
and complementation strains (Fig. 7a). However, we did
observe moderate-to-severe intraosseous inflammation,
minimal-to-mild intraosseous fibrosis and a moderate-to-
severe inflammation without any evidence of intramedul-
lary abscess and periosteal abscess in the bone infected
Fig. 2 Microbial count from bone and K-wires samples. Microbial enumeration from post-mortem bone samples (a-c) and K-wire samples (n = 5)
were obtained to determine intraosseous bacterial survivability and biofilm formation on the K-wires (d-f) on days 4, 8, and 15 post-infection (left
to right). The infected bone sample and K-wires were harvested after each infection period (days 4, 8, and 15). Error bars indicate standard errors
of the means. The bacterial CFUs difference between the USA300 LAC and msaABCR mutant strains was analyzed using one-way ANOVA
followed by a post-hoc Tukey test. A P-value of < 0.05 was considered statistically significant (*p-value < 0.05, **p-value < 0.01, and
***p-value < 0.001)
Sahukhal et al. BMC Microbiology          (2020) 20:324 Page 4 of 20
with msaABCR mutant (Fig. 7a). Bone necrosis with mul-
tiple foci without any sequestrum was observed in bone in-
fected with the msaABCR mutant (Fig. 7a). In addition, we
also observed traces of bacteria in the bones infected by
each of the test strains, which was not evident in the bones
infected on days 4 and 15. Overall, on day 8 after infection,
the sham bone and bones infected with USA300
LAC, msaABCR mutant, and complementation strains
received histopathological scores of 1, 13, 8, and 11,
respectively (Fig. 7b).
Day 15 post-infection
Histopathological analysis of bone infected with sham
group after day 15 showed an active bone healing
process, with no evidence of bone necrosis or acute and
chronic intraosseous and periosteal inflammation
(Fig. 8a). The hallmark feature of bone infected with the
USA300 LAC strain is the presence of large multinucle-
ated osteoclasts and severe bone necrosis with multiple
foci of sequestra formation (Fig. 8a). Moreover, we also
observed severe chronic intraosseous inflammation,
intramedullary abscess, and fibrosis with subperiosteal
abscess formation in the USA300 LAC infected bone
sample (Fig. 8a). Bone infected with msaABCR mutant
showed mild intraosseous and periosteal inflammation.
However, subperiosteal abscess, intramedullary abscess
and fibrosis were not observed in the bone infected
with msaABCR mutant. Although, a single focus of
bone necrosis without any sequestrum formation was
observed, active chondrocyte activity with newly
formed bones were also observed in the msaABCR
infected bone (Fig. 8a). Bone infected with the com-
plementation strain also showed severe intraosseous
inflammation with intramedullary abscess, mild
chronic inflammation with significant intramedullary
fibrosis, and severe chronic inflammation without any
subperiosteal abscess formation (Fig. 8a). Severe bone
necrosis with a single focus of sequestrum was also
observed in the complementation strain infected bone
(Fig. 8a). Overall, sham bone received a total histo-
pathological score of 0, whereas, USA300 LAC,
msaABCR mutant, and complementation strains re-
ceived total scores of 16, 5, and 12 respectively
(Fig. 8b).
Fig. 3 Microbial count from blood, heart, and spleen samples (left to right). The infected blood (a), heart (b), and spleen (c) samples were
processed to enumerate the bacterial CFUs, as described in methods, after each infection period (on days 4, 8, and 15). Error bars indicate
standard errors of the means. The difference in microbial counts between the USA300 LAC and msaABCR mutant strains was analyzed using one-
way ANOVA followed by a post-hoc Tukey test. A P-value of < 0.05 was considered statistically significant
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Host immunological response against staphylococcal
infection
In this study we focused on three main pro-inflammatory
cytokines (IL-1, IL-6, and IL-17) that have been previously
linked to staphylococcal OM infections. We observed a sig-
nificant decrease in IL-1 serum levels in animals infected
with msaABCR mutant relative to USA300 LAC and com-
plementation strains after day 4 and day 8 post-infection.
However, after day 15 post-infection, IL-1 serum levels in
the animals infected with USA300 LAC strain was signifi-
cantly less compared to the animals infected with
msaABCR mutant, complementation strains, and the ani-
mals that received sham K-wires (Fig. 9a). At this moment
we have no clear picture about reduced IL-1 levels in the
blood samples infected with USA300 LAC strains after day
15 post-infection. We did not observe any significant differ-
ences in the IL-6 serum levels in all test strains during all
post-infection periods (Fig. 9b). However, the IL-6 response
in the sham group was significantly higher than in all three
test groups (Fig. 9b). The animals infected with msaABCR
mutant showed significant increase in IL-17 levels relative
to the animals infected with the USA300 LAC and comple-
mentation strains during all post-infection periods (Fig. 9c).
The msaABCR mutant group showed increased ALP
activity
In this study, we measured ALP from the post-mortem
blood samples as a marker of bone reformation. Our re-
sults showed significant increase in ALP activity in the
animals infected with the msaABCR mutant relative to
the animal group infected with USA300 LAC and com-
plementation strains on day 4 and day 15 post-infection
(Fig. 10). However, on day 8 post-infection, we observed
no statistically significant difference in ALP activity be-
tween the test strains (Fig. 10).
The msaABCR proteome suggests defects in proteins
important for staphylococcal OM
Previously, we showed that deletion of the msaABCR op-
eron affected the expression of 238 genes that play roles
in metabolism, virulence, and biofilm development.
msaABCR transcriptomics also showed that several
genes and operons that play roles in pathogenesis (fnbA,
lukF-PV, lukS-PV, sarA, the splABCDEF operon, and the
sspABC operon) were affected [33]. In previous studies
these genes and operons have been implicated in
staphylococcal OM. In this study whole-cell proteomics
Fig. 4 Reconstructed 3D microCT images of bone samples (sham and infected) and cortical bone destruction analysis. The sham and infected
bone samples were harvested after each infection period (on days 4, 8, and 15). The 3D microCT images of sham and infected bone samples (a,
c, and e) and cortical bone destruction analysis of sham and infected bones samples (b, d, and f). Reconstructed 3D images showed significant
bone damage and/or loss by USA300 LAC and complementation strains, which was also revealed by cortical bone destruction analysis. Bone
destruction analysis was subjected to one-way ANOVA followed by a post-hoc Tukey test. Error bars indicate standard errors of the means. A P-
value of < 0.05 was considered statistically significant (**p-value < 0.01, and ***p-value < 0.001)
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of the msaABCR mutant was performed and compared
with the USA300 LAC strain under planktonic and biofilm
growth conditions. Whole-cell proteomics of the msaABCR
mutant under planktonic growth conditions revealed that a
total of 187 proteins were differentially expressed relative to
the USA300 LAC strain (Additional file 3: Table S1),
whereas under biofilm conditions 170 proteins were differ-
entially expressed (Additional file 4: Table S2).
Deletion of the msaABCR operon led to decreased
expression of cell adhesion factors, virulence factors,
proteases, and immunomodulators that are important for
colonizing bone, interacting with osteoblasts / osteoclasts,
modulates secreted virulence factors and evade host
immune system (Table 2). Under planktonic growth condi-
tions, msaABCR proteomes showed reduced production of
cell adhesion factors such as Fibronectin binding protein A
(FnbA), clumping factor A (ClfA), clumping factor B
(ClfB), serine–aspartate repeat-containing protein D
(SdrD), and Extracellular matrix binding protein (Embp),
but showed increased production of serine–aspartate
repeat-containing protein C (SdrC) (Table 2). Under bio-
film growth conditions, only clumping factor A (clfA) was
significantly downregulated, whereas fibronectin-binding
protein A (FnbA), fibronectin-binding protein B (FnbB),
serine–aspartate repeat-containing protein C (SdrC),
serine–aspartate repeat-containing protein D (SdrD), and
Extracellular matrix binding protein (Embp) were upregu-
lated (Table 2).
Staphylococcal virulence factors such as alpha-
hemolysin (Hla) and uncharacterized leucocidin-like pro-
tein 1 (LukL1), which leads to osteoblast death or triggers
osteoclastogenesis and promotes persistence of infection,
were downregulated significantly in the msaABCR mutant
under planktonic conditions (Table 2). Under biofilm
growth condition staphylococcal protein A (SpA) was
downregulated (Table 2). Extracellular proteases, such as
aureolysin, serine proteases, cysteine proteases, and ther-
monucleases, are produced at a significantly higher level
by the msaABCR mutant in planktonic growth conditions.
However, under biofilm growth conditions extracellular
proteases such as cysteine protease and staphopain A are
produced at a significantly higher level (Table 2).
Staphylococcal immune modulator that has been previ-
ously studied to interfere with T-cell mediated host im-
mune system, MAP protein, was undetectable in
msaABCR proteomics under both planktonic and biofilm
growth condition (Table 2). Staphylococcal immune eva-
sion factor, Immunoglobulin-binding protein (Sbi), was
significantly downregulated under planktonic growth con-
dition (Table 2). In addition, several proteins that play
roles in metabolism, DNA replication, transcription and
translation, transport systems, and pathogenesis were also
Fig. 5 Structural indices of sham and infected bones after day 15 post-infection. Analysis of trabecular bone microarchitecture (percentage bone
volume, BV/TV; bone surface/volume ratio, BS/BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular spacing, Tb.Sp; and
trabecular number, Tb.N) were performed. All values were analyzed using one-way ANOVA followed by a post-hoc Tukey test. Error bars indicate
standard errors of the means. A P-value of < 0.05 was considered statistically significant (**p-value < 0.01)
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affected (Additional file 4: Tables S1 and Additional file 5:
Table S2).
Discussion
Community-associated MRSA USA300 LAC strain is
causing increasing numbers of OM cases in the US, with
approximately 100,000 new cases every year [7, 22, 23, 58].
When OM infections are associated with implants and
biofilm, they are very difficult to treat and often lead to
life-threatening complications such as septicemia, venous
thrombosis, and other pathologic fracture conditions [59–
61]. During recent years the common use of implant de-
vices in all surgical fields has caused a drastic increase in
the number of implants and a higher risk of implant-
associated infections. In this study we applied a similar
surgical procedure to study implant-associated biofilm
OM models using a rat model as previously described that
closely mimic the clinical OM infections [39, 40]. We eval-
uated end-point quantification of viable cells from K-wires
and infected bone samples using clinical isolates of CA-
MRSA strain USA300 LAC, msaABCR mutant, and
msaABCR complementation strains. We showed that bio-
film formation on the inserted K-wire implant and the
number of intraosseous bacterial CFUs in the bone sam-
ples were significantly reduced in animals infected with
the msaABCR mutant compared with animals infected
with the USA300 LAC and complementation strains dur-
ing all post-infection periods. We also showed that the ex-
tent of bone damage and/or loss in the msaABCR mutant
infected bone was significantly reduced accompanied by
increased osteoblast response and evidenced the reactive
bone formation. Whereas, USA300 LAC and complemen-
tation strains showed significant bone damage and/or loss,
accompanied by massive osteoclast activation, severe bone
necrosis with multiple foci of sequestra formation, and
with chronic intramedullary abscess and intramedullary fi-
brosis. Therefore, this study showed that the infection of
bone with USA300 LAC strains resulted in an imbalance
of activity between osteoclast and osteoblast activity and
triggered massive bone damage, whereas the impact was
minimal when msaABCR operon was mutated. Thus, we
conclude that the msaABCR operon indeed plays a role in
implant-associated OM infection in a rat model.
Previous studies have shown the role of proinflamma-
tory cytokines and chemokines in maintaining the bal-
ance between bone resorption and formation by
recruiting and activating infiltrated immune cells during
bacterial infection of bone [62–66]. Host cytokines such
as IL-1, IL-6, and IL-17 are important markers of bone
metabolism under pathological conditions [63, 65, 66].
IL-1 is a potent cytokine that is involved in bone resorp-
tion by inducing osteoclast differentiation at inflamma-
tory sites during bone infection [62, 63]. The response of
the TH 17-associated cytokines IL-6 and IL-17 has been
shown to play an important role in bacterial infection in
human S. aureus-associated OM and in animal models
[64, 65, 67]. IL-17A promotes bone formation by stimu-
lating osteoblastic proliferation and differentiation,
which facilitates bone fracture healing [65]. Another
study has shown that an increased IL-6 response acti-
vates osteoclast differentiation, thereby stimulating in-
creased bone resorption activity in an osteoblast cell
culture model [64]. In this study, we showed that infec-
tion with USA300 LAC triggers IL-1 production but re-
presses IL-17 production, thus leading to increased
osteoclast activity. Whereas the msaABCR mutant in-
fected animals showed reduced IL-1 level and increased
IL-17 level, thus supporting increased osteoblast re-
sponse, and reactive bone formation as demonstrated by
Table 1 Histopathological parameters and scoring system to
evaluate bone damage as previously described by Smeltzer et
al. [41]
Histopathological parameters and scoring
Intraosseous acute inflammation (IAI):
0 Not present
1 Minimal-to-mild inflammation with no intramedullary abscess
2 Moderate-to-severe inflammation with no intramedullary abscess
3 Minimal-to-mild inflammation with intramedullary abscess
4 Moderate-to-severe inflammation with intramedullary abscess
Intraosseous chronic inflammation (ICI):
0 Not present
1 Minimal-to-mild chronic inflammation with no significant
intramedullary fibrosis
2 Moderate-to-severe chronic inflammation with no significant
intramedullary fibrosis
3 Minimal-to-mild chronic inflammation with significant
intramedullary fibrosis




1 Minimal-to-mild inflammation with no subperiosteal abscess
formation
2 Moderate-to-severe inflammation with no subperiosteal abscess
formation
3 Minimal-to-mild inflammation with subperiosteal abscess formation
4 Moderate-to-severe inflammation with subperiosteal abscess
formation
Bone necrosis (BN):
0 No evidence of necrosis
1 Single focus of necrosis without sequestrum formation
2 Multiple foci of necrosis without sequestrum formation
3 Single focus of sequestrum
4 Multiple foci of sequestra
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microCT and histopatholgical analysis of infected bone.
While we have not tested other host factors that trigger
bone degradation and/or formation in response to S.
aureus infection, our result showed that msaABCR mu-
tant is defective in stimulating the host immune re-
sponse to trigger osteoclast activation, which mediates
bone degradation. We also observed significantly re-
duced IL-1 serum levels in the animals infected with
USA300 LAC strain compared to the animals infected
with msaABCR mutant, complementation strains, and
the animals that received sham K-wires at day 15 post-
infection. This is in contrast with histopathological data
that showed large multinucleated osteoclasts activity and
severe bone necrosis in the USA300 LAC infected bone
relative to msaABCR mutant infected bone. At this
moment we have no clear picture about reduced IL-1
levels in the blood samples infected with USA300 LAC
strains after day 15 post-infection. In addition, we also
observed increased IL-6 response in sham group com-
pared to all test group. This result is in contrast with
previous result [64] that showed an increased IL-6 re-
sponse in both human and mouse osteoblasts when in-
fected with S. aureus; however, this difference might be
due to a difference in serum level response (this study)
versus the osteoblast local response in the previous
study.
Bone-specific ALP is synthesized by osteoblasts in re-
sponse to bone injury and plays a role in bone matrix
calcification [67]. In studies on long bone fracture heal-
ing, alkaline phosphatase was shown to correlate with
Fig. 6 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 4 post-infection. Bone infected with sham (control)
pins or with the USA300 LAC (wild type), msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows
show the points of insertion of K-wires, green arrows show osteoblast cells, and red arrows show osteoclasts cells. Total histopathological score of
infected bone (b). Histopathological scores were assessed on the basis of intraosseous acute inflammation (IAI, blue), intraosseous chronic
inflammation (ICI, orange), periosteal inflammation (PI, green), and bone necrosis (BN, yellow)
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fracture callus volume, bone formation, and fracture-
healing rates [68–70]. We observed significantly in-
creased ALP activity in the animals infected with
msaABCR mutant. This observation correlates with the
microCT data and bone histopathological data concern-
ing the infected bone, in which the animals that received
a sham pin and those infected with the msaABCR mu-
tant showed increase osteoblast response during all
post-infection periods and evidence of newly formed
bones after day 15 post-infection. Whereas the reduced
ALP activity in animals infected with the wild type and
complementation strains may be the result of increase
osteoclast and less osteoblast activity, increased bone
loss, and with no evidence of any reactive bone forma-
tion even after 15 days post-infection.
Several studies showed that specific staphylococcal
proteins (MSCRAMMS and virulence factors) play a role
during the initial interaction with bone and the progres-
sion of OM infection [12, 42, 43, 47, 49, 50, 67, 71–73].
Bone extracellular matrix and bone cells are important
targets for microbes, especially Staphylococci, once the
bone is exposed to the external environment [6, 12, 74].
In a situation in which medical implants or K-wires are
inserted into the bone, the tissue–implant surface can be
a substrate for the attachment of the host extracellular
matrix proteins fibronectin, fibrinogen, albumin,
Fig. 7 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 8 post-infection. Bone infected with sham (control)
pins or with the USA300 LAC, msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows show the
points of insertion of K-wires, green arrows show osteoblast cells, red arrows show osteoclasts cells, black arrows show bacterial cells, and yellow
arrows show newly formed bones. Total histopathological score of infected bone (b). Histopathological scores were assessed on the basis of
intraosseous acute inflammation (IAI, blue), intraosseous chronic inflammation (ICI, orange), periosteal inflammation (PI, green), and bone necrosis
(BN, yellow)
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vitronectin, and collagen. The host matrix protein-
coated K-wires provide a niche for the attachment of
hosts cells, such as fibroblasts, osteoblasts, and endothe-
lial cells, but also facilitate the attachment of bacteria
such as S. aureus, thus promoting bacterial colonization
and biofilm formation [12, 44, 75–79]. Studies have
shown that staphylococcal clones that possess cna, bbp,
and/or fnbB genes are efficient in attaching to bone
extracellular matrix and concentrating around the osteo-
blasts. Of all the S. aureus strains that cause OM, 10–
60% express cna, bbp, and fnbB, whereas all S. aureus
strains express either fnbA or clumping factors A and B
[57, 80, 81]. S. aureus also produces several virulence
factors that can directly interact with osteoblasts and
bone extracellular matrix, thus triggering increased oste-
cloclastogenesis and causing serious bone damage in the
host [12, 20, 21, 42, 47–50, 61, 67, 71–74, 77]. Crémieux
et al. [48] showed that Panton-Valentine leucocidin
(PVL), produced by CA-MRSA strains, induces in-
creased bone deformation and muscular abscess in an
OM study in a rabbit model. In addition, CA-MRSA
strains of S. aureus also overexpress several other viru-
lence factors, such as α-hemolysin (Hla), phenol-soluble
modulin (psms), and proteases, which are critical viru-
lence factors in several animal models for brain ab-
scesses, skin and soft-tissue infections, and pneumonia
Fig. 8 Hematoxylin and eosin (H&E) stained sections of representative bone samples after day 15 post-infection. Bone infected with sham pins
(control) or with the USA300 LAC, msaABCR mutant, or complementation strains (a) at low (left) and high (right) magnification. Blue arrows show
the points of insertion of the K-wires, green arrows show osteoblast cells, red arrows show osteoclasts cells, yellow arrows show newly formed
bones, and orange arrows show bone necrosis. Total histopathological scores of infected bone (b). Histopathological scores were assessed on the
basis of intraosseous acute inflammation (IAI, blue), intraosseous chronic inflammation (ICI, orange), periosteal inflammation (PI, green), and bone
necrosis (BN, yellow)
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[45, 82, 83]. Loughran et al. [73] studied acute, posttrau-
matic OM using a murine model and compared the ex-
tent of virulence in two clinical isolates of staphylococcal
strains (USA300 LAC and USA200 UAMS-1). They
found that the USA300 LAC strain showed increased
virulence and bone damage compared with the UAMS-1
strain, although the difference was not statistically sig-
nificant. They also found increased osteolysis by a CA-
MRSA strain of S. aureus (USA300 LAC), which was
partly due to its ability to express high levels of
accessory gene regulator (agr), resulting in the produc-
tion of high levels of extracellular toxins, such as phe-
nol-soluble modulins (PSMs) and alpha toxins, which
were shown to be more cytotoxic to osteoblasts in vitro.
In this study we showed that several staphylococcal pro-
teins that facilitates S. aureus to attach bone extracellu-
lar matrix components, infect bone osteoblasts, and
modulates host immune system were significantly af-
fected in the msaABCR mutant (Table 2). Several
staphylococcal virulence factors that are cytotoxic to os-
teoblasts, triggers osteoclastogenesis, and induces bone
loss and/or destruction are also affected in the
msaABCR mutant (Table 2). Several previous studies
have linked increased protease production with defective
biofilm formation, reduced accumulation of secreted
virulence factors, reduced toxicity to osteoblasts and os-
teoclasts cells in vitro, and reduced virulence and attenu-
ation in OM infection [31, 46, 51–53, 73, 84]. Cassat et
al. 2013 [46] showed that extracellular-secreted prote-
ases, mainly aureolysin (Aur), significantly reduced the
abundance of staphylococcal exoproteomes that are im-
portant for host-tissue binding, biofilm formation, inva-
sion of host cells, and the cytolytic factors that trigger
cortical bone destruction. Increased extracellular prote-
ases (SspA, SspB, SspC, and Aur) that leads to increased
cell death and defective biofilm formation was one of
the major phenotypes of msaABCR mutant [31, 32]. In
this study, msaABCR whole cell proteomics analysis also
showed significant production of SspA, SspB, SspC, Aur,
and staphopain A. A study by Rom JS et al., [84] showed
reduced accumulation of alpha toxin (Hla) and extracel-
lular protein A in the msaABCR mutant [84]. They also
showed that deletion of msaABCR leads to the signifi-
cant decrease in accumulation of extracellular proteins
[84]. Findings from this study and study by Rom JS et
al., [84] suggest that decreased pathogenicity and/or de-
creased bone destruction by the msaABCR mutant may
be mainly due to increased proteases production and/or
activity, thus affecting the abundance of extracellular
proteins required for host-tissue binding (cell adhesion
factors), hosts cells invasion, evasion of immune system,
and osteolytic factors such as LukA and alpha hemoly-
sins that have been shown to play role in osteomyelitis
in previous studies [20, 46, 48, 54–56]. However, the
msaABCR proteomics were performed in in vitro condi-
tions and not from in-vivo samples. Therefore, add-
itional studies are needed to further define the
contribution of various msaABCR-regulated molecules
to pathogenesis during osteomyelitis infection.
Conclusions
In this study we showed that the msaABCR mutant is
defective in several cell-surface adhesion protein factors
that are important for interacting with and colonizing
host cells, such as osteoblasts, and host cell matrix, in-
cluding bone extracellular matrix. In addition, the
msaABCR mutant is also defective in some important
virulence factors, such as hemolysin and leukocidins,
Fig. 9 Immune response against staphylococcal bone infection.
Blood samples were collected after each infection period (on days 4,
8 and 15) and were processed to obtain serum. Quantitative
measurements of IL-1 (a), IL-17 (b), and IL-6 (c) were performed. All
values were analyzed using one-way ANOVA followed by a post-hoc
Tukey test. Error bars indicate standard errors of the means. A P-
value of < 0.05 was considered statistically significant
(**p-value < 0.01)
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which can kill host cells, such as osteoblasts, and their
dissemination that can lead to infection progression.
Thus, the msaABCR operon mutant is defective in
implant-associated in vivo biofilm formation on K-wires,
and decreased intraosseous survivability, that led to re-
duced bone damage and therefore it plays a role in
implant-associated chronic OM in rat model. The find-
ings from this study provide additional insights into the
pathogenesis of implant-associated chronic OM infec-
tions by USA300 LAC and explore the potential for tar-
geting msaABCR for therapy. It should be however
noted that while we observed reactive bone formation in
the msaABCR mutant similarly to the sham controls, the
msaABCR mutant still caused some degree of bone de-
struction. This implicates other virulence factors, whose
production were not impacted by the deletion of
msaABCR operon and should be investigated further to
fully understand osteomyelitis pathogenesis caused by S.
aureus.
Methods
Bacterial strains and growth media
Overnight bacterial cultures (the USA300 LAC strain, the
msaABCR operon deletion mutant (msaABCR mutant)
strain [32], and a complementation strain [32] were pre-
pared by inoculating cells from frozen culture stocks into
culture tubes containing 5mL of freshly prepared tryptic
soy broth (TSB) and incubating at 37 °C with continuous
shaking at 225 rpm. The overnight cultures were diluted 1:
10 in fresh medium (TSB or biofilm medium: TSB supple-
mented with 3% sodium chloride and 0.5% glucose) and
incubated for 2 h to prepare a starter culture for further ex-
periments. The starter culture was normalized to an
optical density at 600 nm (OD600) of 0.05 (2X107
CFUs per ml) in prewarmed TSB for planktonic
growth conditions and in prewarmed biofilm media
for biofilm growth conditions.
Sprague Dawley rats and experimental design
This study included 96 animals randomly divided using
a random number generator into 4 groups (n = 24)
USA300 LAC, msaABCR mutant, complementation, and
sham. All animals underwent a surgical procedure to
place a K-wire with or without bacteria, and three ani-
mals per group were sacrificed immediately following
the surgical procedure to assess bacterial load. The
remaining 21 animals per group (7 animals per time
point based upon power analysis) were euthanized on
days 4, 8, and 15 by an overdose of 5% isoflurane (2-
chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane)
followed by bilateral pneumothorax prior to collection
of blood, vital organs, and bone. Post-mortem blood
samples were processed to obtain plasma and serum, ali-
quoted into storage tubes, and stored at − 80 °C. Five
legs were placed on ice and processed for bacterial
counts, while 2 legs were processed for microCT analysis
of bone followed by histopathological analysis. Vital or-
gans (heart, spleen, kidneys, and lungs) were collected
and immediately frozen at − 80 °C for analysis of bacter-
ial load resulting from dissemination from the infection
site. Organ samples for histopathological studies were
placed in buffered formalin.
Fig. 10 Alkaline phosphatase (ALP) activity measurements in serum. Alkaline phosphatase activity in serum was measured after each infection
period (on days 4, 8, and 15) as an indicator of bone metabolic activity. All values were analyzed using one-way ANOVA followed by a post-hoc
Tukey test. Error bars indicate standard errors of the means. A P-value of < 0.05 was considered statistically significant (**p-value < 0.01)
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An implant-associated OM model using the Sprague
Dawley rat (SD-rat)
The surgical procedure was performed as previously de-
scribed for an animal model of chronic OM, with slight
modifications [39, 40]. In brief, the sterile K-wires (0.035″
× 7″ TROCAR-TROCAR, Jorgensen Laboratories Inc.,
Loveland, CO) were aseptically cut in half (0.035″ × 3.5″)
and coated with SD-RAT plasma overnight at 4 °C to fa-
cilitate colonization with S. aureus cells. Biofilm formation
on the K-wires was initiated by incubating them at 37 °C
for 24 h with the test strains (USA300 LAC, msaABCR
mutant, and complementation) pre-normalized to an
OD600 of 0.05 (2X10
7 CFUs per ml). The biofilm-coated
K-wires were stored at − 80 °C until use and for not more
than 7 days. Six biofilm-coated K-wires were used to enu-
merate the bacterial CFUs prior to the surgical procedure
to evaluate the number of initial bacterial CFUs. Sterile K-
wires coated with SD-Rat plasma were used as negative
control (sham infection). The K-wires colonized with test
strains were inserted into the bones of Sprague Dawley
rats (SD-Rat) to induce OM.
Following approval from the University of Mississippi
Medical Center institutional Animal Care and Use Com-
mittee (IACUC), a total of 96 SD-rats weighing 250–300 g
were purchased from Charles River Labs. The animals were
housed under a 12-h day/night light cycle and allowed
Table 2 Proteins involved in progression and pathogenicity of staphylococcal osteomyelitis infection
Proteins that interacts with bone matrix and osteoblasts cells
MSCRAMM(s) Functional response Mean peptide spectral count References









Fibronectin binding protein A (FnbA) Internalization 2 0 81 128 [42, 43]
Fibronectin binding protein B (FnbB) Internalization – – 0 11* [42, 43]
Serine-aspartate repeat-containing
proteins (SdrC)
Colonization 0 8* – – [43]
Serine-aspartate repeat-containing
proteins (SdrD)
Colonization 36 12* 0 2 [43]
Extracellular matrix binding protein
(Embp)
Colonization 7 2* 0 3* [44]
Toxins and exoproteins involved in osteoblast cytotoxicity and induce osteoclastogenesis
Toxins / exoproteins
Alpha hemolysin (Hla) Osteoblast/osteoclast cell death 19 6* – – [45, 46]




Osteoblast cytotoxicity 215 83* 232 332 [20, 48]




– – 12 5* [47, 49, 50]
Other virulence factors that plays role in osteomyelitis infection and immune evasion
Virulence factors
Serine protease (sspA) modulates secreted osteolytic factors 0 38* – – [46, 51–53]
Cysteine protease (SspB) 12 66* – –
Cysteine protease (SspC) 0 12* 7 22*
Aureolysin (Aur) 0 60* – –
Staphopain A immunomodulatory protein that
blocks neutrophil recruitment
37 31 0 5* [54]
Map protein Immunomodulators interfering T cell
mediated response
85 0* 116 0* [55]
Immunoglobulin-binding protein sbi Immune evasion factor 46 19* 98 114 [56]
Clumping factor A (ClfA) Unknown 11 6 16 5* [57]
Clumping factor B (ClfB) Unknown 9 3* 33 44 [57]
Proteins differentially expressed ≥2-fold is considered significant (*) and is shown in bold
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access to food and water ad libitum. The animals were ac-
climated for 1 week prior to surgical manipulation. The ani-
mals were randomly divided using a random number
generator into into 3 sets of 4 groups (n = 24), and a K-wire
was inserted surgically. Isoflurane (2%) was used for
anesthesia induction followed by intraperitoneal injection
of ketamine (75mg/kg) and xylazine (5mg/kg) for surgical
anesthesia, and a presurgical dose of Buprenorphine (Tem-
gesic, Schering-Plough, Brussels, Belgium) (0.05mg/Kg) for
analgesia. The skin above the bone was disinfected using
70% ethanol, providone iodine scrub, providone, followed
by 70% ethanol. Following the aseptic surgical preparation,
the position of the bone metaphysis was determined by pal-
pation, and the K-wire pin was implanted transcortically
through the metaphysis. Afterwards, the pin was bent on
both ends and cut adjacent to the skin to secure it in the
bone. Six hours post-surgery, the animals received a second
subcutaneous injection of 0.10mg/kg buprenorphine (Tem-
gesic, Schering-Plough, Brussels, Belgium). Following sur-
gery, the animals were housed individually for the first 3
days post-surgery, provided Buprenorphine (0.1mg/kg) for
pain every 12 h during the first 2 days and then assessed for
pain daily, and analgesics were provided as needed.
Wounds were evaluated for infection daily for the duration
of the experiment. Animal cages were cleaned daily for the
first 3 days, then every other day for the remainder of the
experiment. The bedding was collected into biohazard bags,
and the cages disinfected before entering the cage wash
area.
Bacterial counts
To determine the number of bacterial inoculums or
colony-forming units (CFUs) prior to infection, the K
wires coated with each bacterial strain (3 animals per
group) were inserted in rat bone. All the animals were
euthanized immediately, and K-wires and bone samples
were harvested to enumerate the bacterial CFUs retained
in the bone and on the K-wires after surgery.
Bone samples
Infected bone samples (5 per group) with K-wire pins
were carefully excised from the bone, and the bone shaft
was removed using a scalpel. The bone was cut into
smaller sections, homogenized in the presence of liquid
nitrogen using mortar and pestle. The samples were sus-
pended in 5 ml of 1X PBS, and plated in tryptic soy agar
(TSA) agar plates after serial dilutions in sterile 1x PBS
to determine the viable bacterial count, as previously de-
scribed [39].
K-wire samples
The K-wires (5 per group) were carefully removed from
the infected bone samples and rinsed twice with sterile
1x PBS. The K-wires were suspended in 5 ml of sterile
1x PBS and sonicated for 30 min in a 2.8-L ultrasonic
bath (Fischer Scientific) to release the bacteria from the
biofilms that had formed on the pins. Appropriate serial
dilutions were performed and plated on TSA media to
count the total number of bacterial CFUs present on the
K-wire samples.
Blood samples
The blood samples were collected from all animals for
enumeration of bacterial CFUs (7 animals per group).
One hundred microliters of blood samples were serially
diluted in 1 ml of 1X PBS and plated on TSA media to
count the total number of bacterial CFUs present in the
blood samples after overnight incubation at 37 °C.
Organ samples
Six organ samples per group (heart, spleen, liver, kidney,
and lung) were collected in a sterile plastic container
and immediately stored at –80 °C until use. They were
later retrieved from the − 80 °C freezer and rinsed with
sterile 1x PBS thrice. The organ samples were cut into
small pieces using a sterile surgical blade and transferred
to a 15-ml FastPrep tube containing 5 ml of an equal
mixture of 0.5-mm and 1-mm zirconia/silica beads
(BioSpec Products). Five milliliters of sterile 1x PBS was
added, and the beads beating was performed in
FastPrep-24 instrument (4 times, with a setting of 6.5M/
S for 60 s and 2min off time on ice). The cell debris was
removed by a quick spin at 2000 x g for 2 min, and the
supernatant was transferred to another 15-ml tube. The
samples were serially diluted and plated on TSA media
to count the total number of bacterial CFUs present in
the organ samples after overnight incubation at 37 °C.
Micro-computed tomography (microCT) analysis of
infected bone
High-resolution analysis of cortical thickness, cortical
bone destruction, and underlying trabecular bone in the
sham group and the bacteria-treated groups was deter-
mined by microCT imaging using a 1172 μCT SkyScan
scanner with a 10-megapixel camera (Skyscan, Aartse-
laar, Belgium) and the manufacturer’s analytical soft-
ware. The SkyScan scanning parameters were set up as
previously described by Tucci et al. [85]. Structural indi-
ces were calculated using CTAn software (Skyscan, Aart-
selaar, Belgium) and BoneJ software [86]. Differences in
cortical bone destruction were analyzed using one-way
ANOVA followed by a post-hoc Tukey test. A P-value
of < 0.05 was considered statistically significant.
Histopathological analysis of infected bone
For histopathological analysis, samples of the proximal
half of the bone were fixed in neutral-buffered formalin
solution, decalcified using Cal-Ex™ solution, embedded
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in OCT for frozen sectioning, and cut into 10-μm sec-
tions. The sections were stained with hematoxylin and
eosin (H & E). Histopathological scores were determined
for intraosseous acute inflammation (IAI), intraosseous
chronic inflammation (ICI), periosteal inflammation (PI),
and bone necrosis (BN) using the system previously de-
scribed by Smeltzer et al. [41]. Each parameter was
scored on a 5-point scale (0–4), and the scores for each
section were added together to provide a total histo-
pathological score, as shown in Table 1.
ELISA testing for IL-6, IL-1, and IL-17
Commercially available colorimetric sandwich enzyme-
linked immunosorbent (ELISA) assays were used to ob-
tain quantitative measurements of IL-1, IL-17, and IL-6
(R&D Systems). The manufacturer’s protocols were
followed to determine the concentrations of cytokines in
the sample. Briefly, either 25 μL of standard or plasma
sample was dispensed in duplicate into microtiter plate
wells coated with IL-6, IL-17, or IL-1. The plate was in-
cubated for 2 h to allow the cytokine present in the sam-
ple or standard to bind to the immobilized antibody.
The plates were washed with 100 μL of the wash buffer
supplied by the manufacturer three times, and then
25 μL of a second biotinylated cytokine antibody was
added and the plate incubated overnight at 4 °C. Follow-
ing the overnight incubation, the plate was washed three
additional times with 100 μL of wash buffer per wash.
After washing, the unbound biotinylated antibody, which
was conjugated to HRP with streptavidin, was pipetted
into the wells, and incubated for 1 h. The wells were
washed again in a similar manner, and 50 μL of TMB
substrate solution were added to the wells for 20 min
followed by the addition of 50 μL of stop solution. The
intensity of the color in the samples was compared with
a standard curve generated by the color intensity of the
concentration standards at 405 nm, and the amount of
cytokine in the samples was thereby determined.
Alkaline phosphatase (ALP) assay
The activity of ALP in serum was determined by meas-
uring the rate of hydrolysis of various phosphate esters
under specified conditions. In the Pointe Scientific (Can-
ton, MI) kinetic assay, p-nitrophenyl phosphate is hydro-
lyzed to p-nitrophenol and inorganic phosphate and
detected at 405 nm, and the rate of hydrolysis is directly
proportional to ALP activity. Working reagents were
prepared according to the manual instructions. One
milliliter of reagent was pipetted into a spectrophotom-
eter cuvette and warmed to 37 °C for 5 min. The refer-
ence cuvette contained water and was used as the blank.
A plasma aliquot of 0.25 mL was added to warm reagent
and allowed to incubate at 37 °C for an additional mi-
nute. The absorbance was determined at 405 nm, and
the cuvette was then placed back in the 37 °C heat block
and measured again after 5 and 10 min. The average ab-
sorbance difference per minute was calculated and
multiplied by a factor of 2187 to convert the results to
IU/L.
Proteomics: analysis of the Staphylococcus aureus
proteome using a label-free strategy
For whole cell proteomics analysis, the cells were grown
to OD600 of 1.5 in TSB broth for planktonic growth
condition. The cells were collected, washed twice with
ice cold 1X PBS and were used for whole cell proteomics
analysis. For biofilm growth condition, the biofilm was
grown in flow cells (Stovall Life Science, Greensboro,
NC). The flow cells were pre-coated with human plasma.
One hundred microliter of starter bacterial suspension
were inoculated into the flow cells by injection and
allowed to incubate at 37 °C for 1 h. Biofilm media was
then pumped through the flow cells at a flow rate of 0.5
ml/min for 24 h. The biofilm cells were collected,
washed twice with ice cold 1X PBS and were used for
whole cell proteomics analysis.
Trypsin digestion
Protein extraction was performed using urea buffer (8M
urea, 150 mM NaCl, 50 mM Tris-HCl, pH 8) and mech-
anical disruption with 1.0-mm silica beads in a Bullet
Blender (Next Advance). Samples were centrifuged at
10,000 x g for 10 min and the supernatant removed. The
protein concentration was determined using a Qubit
fluorometry assay (Invitrogen). Protein concentrations
were normalized with lysis buffer. Five hundred micro-
grams of protein from each sample was reduced with 10
mM dithiothretiol for 30 min at room temperature and
alkylated with 10 mM iodoacetamide for 45 min at room
temperature. Trypsin was added at a 1:30 enzyme-to-
substrate ratio, and urea was diluted to 1.6M with 25
mM ammonium bicarbonate. The reaction was termi-
nated with 0.1% trifluoroacetic acid (TFA) and the sus-
pension clarified by centrifugation at 10,000 x g for 10
min.
Solid-phase extraction (SPE)
Cleared peptide solution was processed by SPE on a Wa-
ters HLB PRiME with 30-mg-capacity cartridges using 5
psi. In brief, samples were loaded directly onto the cart-
ridge per the vendor protocol and washed with 2 × 1mL
of 0.1% TFA. Peptides were eluted with 2 × 500 μL of
90% acetonitrile with 0.1% TFA, and the peptide concen-
trations were determined by UV absorbance at 280 nm.
Mass spectrometry
Two micrograms of each sample were analyzed by nano-
LC-MS/MS (MSBioworks, Ann Arbor, MI, USA) with a
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Waters NanoAcquity HPLC system interfaced to a Ther-
moFisher Q Exactive mass spectometer using a 4-h
reverse-phase gradient. Peptides (30 μL) were loaded on
a trapping column and eluted over a 75-μm analytical
column at 350 nL/min, and both columns were packed
with Jupiter Proteo resin (Phenomenex, Torrance, CA,
USA). The mass spectrometer was operated, and the
data was obtained in data dependent mode with the
Orbitrap operating settings as previously described by
Franco M et al. [87].
Data processing
A composite database comprising the 20 sequenced S.
aureus strains was created. The strains were 04–02981,
bovine RF122 (ET3–1), COL, ED98, JH1, JH9, JKD6159,
MRSA ST398 (isolate S0385), MRSA252, MSSA476,
Mu3 (ATCC 700698), Mu50 (ATCC 700699), MW2,
N315, NCTC 8325, Newman, TW20 (0582), USA300
(TCH1516), and ED133. Data were analyzed using Mas-
cot software with the parameter settings as previously
described by Franco M et al. [87]. Mascot DAT files
were parsed for processing with Scaffold software for
validation, filtering, and to create a nonredundant list
per sample. Data were filtered using a 1% protein and
peptide false discovery rate (FDR) and required at least
one unique peptide per protein.
Comparative gene ontology analysis of proteomics data
As a part of the functional genomic analysis of our
whole-cell proteomics data, we performed gene ontology
(GO) classification of differentially expressed (≥3-fold)
proteins, as previously described [33]. We used a freely
available web-based GO analysis tool (Comparative GO,
[88, 89]) to better understand the differentially expressed
proteins in terms of the biological pathways involved.
Statistical analysis
All statistical analyses to test for significance in this
study were done using OriginPro software (Originlab,
Northampton, MA). A significance level of 0.05 was set
as the cutoff value while performing statistical analyses.
All the data obtained from CFU experiments were ana-
lyzed using one-way ANOVA followed by a post-hoc
Tukey test.
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Additional file 1: Fig. S1. Microbial counts from vital organ samples to
study staphylococcal dissemination. The organ samples (n = 6): liver (a),
kidney (b), and lung (c) from sham and infected animals were harvested
after each infection period (on days 4, 8, and 15) and were processed to
enumerate the bacterial CFUs, as described in methods. The difference in
microbial count between the USA300 LAC and msaABCR mutant strains
was analyzed using one-way ANOVA followed by a post-hoc Tukey test.
Error bars indicate standard errors of the means. A P-value of < 0.05 was
considered statistically significant.
Additional file 2: Fig. S2. Structural indices of sham and infected
bones after day 4 post-infection. Analysis of bone trabecular microarchi-
tecture (percentage bone volume, BV/TV; bone surface/volume ratio, BS/
BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular
spacing, Tb.Sp; and trabecular number, Tb.N) were performed using Nre-
con and BoneJ software. All values were analyzed using one-way ANOVA
followed by a post-hoc Tukey test. Error bars indicate standard errors of
the means. A P-value of < 0.05 was considered statistically significant
(**p-value < 0.01).
Additional file 3: Fig. S3. Structural indices of sham and infected
bones after day 8 post-infection. Analysis of trabecular bone microarchi-
tecture (percentage bone volume, BV/TV; bone surface/volume ratio, BS/
BV; trabecular pattern factor, Tb.Pf; trabecular thickness, Tb.Th; trabecular
spacing, Tb.Sp; and trabecular number, Tb.N) were performed Nrecon
and BoneJ software. All values were analyzed using one-way ANOVA
followed by a post-hoc Tukey test. Error bars indicate standard errors of
the means. A P-value of < 0.05 was considered statistically significant
(**p-value < 0.01).
Additional file 4: Table S1. Comparative Gene Enrichment analysis of
msaABCR proteomics under planktonic conditions.
Additional file 5: Table S2. Comparative gene enrichment analysis of
msaABCR proteomes under biofilm growth condition.
Abbreviations
CA-MRSA: community-associated methicillin-resistant S. aureus;; SD-
Rat: Sprague Dawley Rat; OM: Osteomyelitis; μCT: microCT; CFUs: Colony
forming units; °C: Degree Celsius; TSB: Tryptic soy broth; Biofilm medium: TSB
supplemented with 3% sodium chloride and 0.5% glucose; H&E: Hematoxylin
and eosin; IAI: Intraosseous acute inflammation; ICI: Intraosseous chronic
inflammation; PI: Periosteal inflammation; BN: Bone necrosis (BN);
IL: Interleukin; BV/TV: percent bone volume; BS/BV: bone surface/volume
ratio; Tb.Pf: trabecular pattern factor; Tb.th: trabecular thickness;
Tb.N: trabecular number; TB.Sp: trabecular separation; HRP: Horseradish
peroxidase; TMB: Tetramethylbenzidine; ALP: Alkaline phosphatase; IU/
L: International Units Per Litre; SPE: Solid phase extraction; TFA: trifluoroacetic
acid; GO: Gene ontology; mg/kg: milligram per kilogram; PBS: Phosphate
buffer saline; ml: milliliter; mm: milliliter; μl: microliter
Acknowledgements
We gratefully acknowledge Dr. Lindsey Shaw for sharing S. aureus strain
USA300 LAC. We are also grateful to Bina L. jayana and our undergraduate
students Megan Mullis, Latoyia Downs, Sarah Simmons, and Brittany Trunnel
for their valuable technical help with this study.
Authors’ contributions
GSS, MOE, MT, and HB designed the project. GSS, MOE, MT, GW, and HB
performed the experiments. GSS, MOE, MT, and HB wrote the manuscript. All
authors read and approved the final manuscript.
Funding
This work was supported by the Mississippi INBRE, funded by an Institutional
Development Award (IDeA) from the National Institute of General Medical
Sciences of the National Institutes of Health under grant number
P20GM103476. The funding source had no role in the design of the study
and collection, analysis, and interpretation of data and writing of the
manuscript.
Availability of data and materials
All data generated or analyzed during this study are included in this
published article [and its supplementary information files].
Ethics approval and consent to participate
The study was approved by the University of Mississippi Medical Center
institutional Animal Care and Use Committee [Number: D16–00174 (A3275–
01)], The University of Mississippi Medical Center, Jackson, MS 39216.




The authors declare that they have no competing interests.
Author details
1Present Address: Center for Molecular and Cellular Biosciences, The
University of Southern Mississippi, 118 College Drive # 5018, Hattiesburg, MS
39406, USA. 2Department of Orthopaedics, University of Mississippi Medical
Center, Jackson, MS, USA.
Received: 31 October 2019 Accepted: 2 September 2020
References
1. Crum NF. The emergence of severe, community-acquired methicillin-resistant
Staphylococcus aureus infections. Scand J Infect Dis. 2005;37(9):651–6.
2. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of
methicillin-resistant Staphylococcus aureus infection in children’s hospitals
in the United States. Clin Infect Dis. 2009;49(1):65–71.
3. Iwamoto M, Mu Y, Lynfield R, Bulens SN, Nadle J, Aragon D, Petit S, Ray SM,
Harrison LH, Dumyati G, et al. Trends in invasive methicillin-resistant
Staphylococcus aureus infections. Pediatrics. 2013;132(4):e817–24.
4. Arnold SR, Elias D, Buckingham SC, Thomas ED, Novais E, Arkader A, Howard
C. Changing patterns of acute hematogenous osteomyelitis and septic
arthritis: emergence of community-associated methicillin-resistant
Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703–8.
5. Gwynne-Jones DP, Stott NS. Community-acquired methicillin-resistant
Staphylococcus aureus: a cause of musculoskeletal sepsis in children. J
Pediatr Orthop. 1999;19(3):413–6.
6. Lew DP, Waldvogel FA. Osteomyelitis. Lancet. 2004;364(9431):369–79.
7. Martinez-Aguilar G, Avalos-Mishaan A, Hulten K, Hammerman W, Mason EO
Jr, Kaplan SL. Community-acquired, methicillin-resistant and methicillin-
susceptible Staphylococcus aureus musculoskeletal infections in children.
Pediatr Infect Dis J. 2004;23(8):701–6.
8. Weichert S, Sharland M, Clarke NM, Faust SN. Acute haematogenous
osteomyelitis in children: is there any evidence for how long we should
treat? Curr Opin Infect Dis. 2008;21(3):258–62.
9. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997;336(14):999–1007.
10. Arciola CR, An YH, Campoccia D, Donati ME, Montanaro L. Etiology of
implant orthopedic infections: a survey on 1027 clinical isolates. Int J Artif
Organs. 2005;28(11):1091–100.
11. Campoccia D, Montanaro L, Arciola CR. The significance of infection related
to orthopedic devices and issues of antibiotic resistance. Biomaterials. 2006;
27(11):2331–9.
12. Montanaro L, Testoni F, Poggi A, Visai L, Speziale P, Arciola CR. Emerging
pathogenetic mechanisms of the implant-related osteomyelitis by
Staphylococcus aureus. Int J Artif Organs. 2011;34(9):781–8.
13. Berendt T, Byren I. Bone and joint infection. Clin Med (Lond). 2004;4(6):510–8.
14. Ciampolini J, Harding KG. Pathophysiology of chronic bacterial
osteomyelitis. Why do antibiotics fail so often? Postgrad Med J. 2000;
76(898):479–83.
15. Corvec S, Portillo ME, Pasticci BM, Borens O, Trampuz A. Epidemiology and
new developments in the diagnosis of prosthetic joint infection. Int J Artif
Organs. 2012;35(10):923–34.
16. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic
joints. N Engl J Med. 2009;361(8):787–94.
17. Montanaro L, Speziale P, Campoccia D, Ravaioli S, Cangini I, Pietrocola G,
Giannini S, Arciola CR. Scenery of Staphylococcus implant infections in
orthopedics. Future Microbiol. 2011;6(11):1329–49.
18. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):
302–45.
19. Darouiche RO. Treatment of infections associated with surgical implants. N
Engl J Med. 2004;350(14):1422–9.
20. Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE, Hammerman WA, Kaplan
SL. Panton-Valentine leukocidin genes are associated with enhanced
inflammatory response and local disease in acute hematogenous
Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006;117(2):433–40.
21. Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, Vanhems P, Floret D,
Etienne J. Pediatric bone and joint infections caused by Panton-Valentine
leukocidin-positive Staphylococcus aureus. Pediatr Infect Dis J. 2007;26(11):
1042–8.
22. McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hulten
KG. Increase of the USA300 clone among community-acquired methicillin-
susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect
Dis J. 2007;26(12):1122–7.
23. Carrillo-Marquez MA, Hulten KG, Hammerman W, Mason EO, Kaplan SL.
USA300 is the predominant genotype causing Staphylococcus aureus septic
arthritis in children. Pediatr Infect Dis J. 2009;28(12):1076–80.
24. Carrel M, Perencevich EN, David MZ. USA300 methicillin-resistant
Staphylococcus aureus, United States, 2000-2013. Emerg Infect Dis. 2015;
21(11):1973–80.
25. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME. Osteomyelitis and
the role of biofilms in chronic infection. FEMS Immunol Med Microbiol.
2008;52(1):13–22.
26. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial
infections. Clin Pharmacol Ther. 2007;82(2):204–9.
27. Lewis K. Multidrug tolerance of biofilms and persister cells. Curr Top
Microbiol Immunol. 2008;322:107–31.
28. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J
Med Microbiol. 2002;292(2):107–13.
29. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW,
Mandrekar JN, Osmon DR. Outcome of prosthetic joint infections treated with
debridement and retention of components. Clin Infect Dis. 2006;42(4):471–8.
30. Lee J, Kang CI, Lee JH, Joung M, Moon S, Wi YM, Chung DR, Ha CW, Song
JH, Peck KR. Risk factors for treatment failure in patients with prosthetic
joint infections. J Hosp Infect. 2010;75(4):273–6.
31. Sahukhal GS, Batte JL, Elasri MO. msaABCR operon positively regulates
biofilm development by repressing proteases and autolysis in
Staphylococcus aureus. FEMS Microbiol Lett. 2015;362(4):1–10.
32. Sahukhal GS, Elasri MO. Identification and characterization of an operon,
msaABCR, that controls virulence and biofilm development in
Staphylococcus aureus. BMC Microbiol. 2014;14:154.
33. Sahukhal GS, Pandey S, Elasri MO. msaABCR operon is involved in persister
cell formation in Staphylococcus aureus. BMC Microbiol. 2017;17(1):218.
34. Batte JL, Sahukhal GS, Elasri MO. MsaB and CodY interact to regulate
Staphylococcus aureus capsule in a nutrient-dependent manner. J Bacteriol.
2018;200(17):e00294–18.
35. Batte JL, Samanta D, Elasri MO. MsaB activates capsule production at the
transcription level in Staphylococcus aureus. Microbiology. 2016;162(3):575–89.
36. G CB, Sahukhal GS, Elasri MO. Role of the msaABCR operon in cell wall
biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus
aureus. Antimicrob Agents Chemother. 2019;63(10):e00680–19.
37. Pandey S, Sahukhal GS, Elasri MO. The msaABCR operon regulates the
response to oxidative stress in Staphylococcus aureus. J Bacteriol. 2019;
201(21):e00417–9.
38. Caballero CJ, Menendez-Gil P, Catalan-Moreno A, Vergara-Irigaray M, Garcia
B, Segura V, Irurzun N, Villanueva M, Ruiz de Los Mozos I, Solano C, et al.
The regulon of the RNA chaperone CspA and its auto-regulation in
Staphylococcus aureus. Nucleic Acids Res. 2018;46(3):1345–61.
39. Jorgensen NP, Meyer RL, Dagnaes-Hansen F, Fuursted K, Petersen E. A
modified chronic infection model for testing treatment of Staphylococcus
aureus biofilms on implants. PLoS One. 2014;9(10):e103688.
40. Li D, Gromov K, Soballe K, Puzas JE, O'Keefe RJ, Awad H, Drissi H, Schwarz
EM. Quantitative mouse model of implant-associated osteomyelitis and the
kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop
Res. 2008;26(1):96–105.
41. Smeltzer MS, Thomas JR, Hickmon SG, Skinner RA, Nelson CL, Griffith D, Parr
TR Jr, Evans RP. Characterization of a rabbit model of staphylococcal
osteomyelitis. J Orthop Res. 1997;15(3):414–21.
42. Vazquez V, Liang X, Horndahl JK, Ganesh VK, Smeds E, Foster TJ, Hook M.
Fibrinogen is a ligand for the Staphylococcus aureus microbial surface
components recognizing adhesive matrix molecules (MSCRAMM) bone
sialoprotein-binding protein (Bbp). J Biol Chem. 2011;286(34):29797–805.
43. Tung H, Guss B, Hellman U, Persson L, Rubin K, Ryden C. A bone
sialoprotein-binding protein from Staphylococcus aureus: a member of the
staphylococcal Sdr family. Biochem J. 2000;345(Pt 3):611–9.
44. Christner M, Franke GC, Schommer NN, Wendt U, Wegert K, Pehle P, Kroll G,
Schulze C, Buck F, Mack D, et al. The giant extracellular matrix-binding
protein of Staphylococcus epidermidis mediates biofilm accumulation and
attachment to fibronectin. Mol Microbiol. 2010;75(1):187–207.
Sahukhal et al. BMC Microbiology          (2020) 20:324 Page 18 of 20
45. Kielian T, Cheung A, Hickey WF. Diminished virulence of an alpha-toxin
mutant of Staphylococcus aureus in experimental brain abscesses. Infect
Immun. 2001;69(11):6902–11.
46. Cassat JE, Hammer ND, Campbell JP, Benson MA, Perrien DS, Mrak LN,
Smeltzer MS, Torres VJ, Skaar EP. A secreted bacterial protease tailors the
Staphylococcus aureus virulence repertoire to modulate bone remodeling
during osteomyelitis. Cell Host Microbe. 2013;13(6):759–72.
47. Jin T, Zhu YL, Li J, Shi J, He XQ, Ding J, Xu YQ. Staphylococcal protein A,
Panton-Valentine leukocidin and coagulase aggravate the bone loss and
bone destruction in osteomyelitis. Cell Physiol Biochem. 2013;32(2):322–33.
48. Cremieux AC, Dumitrescu O, Lina G, Vallee C, Cote JF, Muffat-Joly M, Lilin T,
Etienne J, Vandenesch F, Saleh-Mghir A. Panton-valentine leukocidin
enhances the severity of community-associated methicillin-resistant
Staphylococcus aureus rabbit osteomyelitis. PLoS One. 2009;4(9):e7204.
49. Claro T, Widaa A, O'Seaghdha M, Miajlovic H, Foster TJ, O'Brien FJ, Kerrigan
SW. Staphylococcus aureus protein A binds to osteoblasts and triggers
signals that weaken bone in osteomyelitis. PLoS One. 2011;6(4):e18748.
50. Widaa A, Claro T, Foster TJ, O'Brien FJ, Kerrigan SW. Staphylococcus aureus
protein A plays a critical role in mediating bone destruction and bone loss
in osteomyelitis. PLoS One. 2012;7(7):e40586.
51. Beenken KE, Mrak LN, Zielinska AK, Atwood DN, Loughran AJ, Griffin LM,
Matthews KA, Anthony AM, Spencer HJ, Skinner RA, et al. Impact of the
functional status of saeRS on in vivo phenotypes of Staphylococcus aureus
sarA mutants. Mol Microbiol. 2014;92(6):1299–312.
52. Mrak LN, Zielinska AK, Beenken KE, Mrak IN, Atwood DN, Griffin LM, Lee CY,
Smeltzer MS. saeRS and sarA act synergistically to repress protease
production and promote biofilm formation in Staphylococcus aureus. PLoS
One. 2012;7(6):e38453.
53. Zielinska AK, Beenken KE, Joo HS, Mrak LN, Griffin LM, Luong TT, Lee CY,
Otto M, Shaw LN, Smeltzer MS. Defining the strain-dependent impact of the
Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of
Staphylococcus aureus. J Bacteriol. 2011;193(12):2948–58.
54. Laarman AJ, Mijnheer G, Mootz JM, van Rooijen WJ, Ruyken M, Malone CL,
Heezius EC, Ward R, Milligan G, van Strijp JA, et al. Staphylococcus aureus
Staphopain A inhibits CXCR2-dependent neutrophil activation and
chemotaxis. EMBO J. 2012;31(17):3607–19.
55. Lee LY, Miyamoto YJ, McIntyre BW, Hook M, McCrea KW, McDevitt D, Brown
EL. The Staphylococcus aureus map protein is an immunomodulator that
interferes with T cell-mediated responses. J Clin Invest. 2002;110(10):1461–
71.
56. Smith EJ, Visai L, Kerrigan SW, Speziale P, Foster TJ. The Sbi protein is a
multifunctional immune evasion factor of Staphylococcus aureus. Infect
Immun. 2011;79(9):3801–9.
57. Campoccia D, Speziale P, Ravaioli S, Cangini I, Rindi S, Pirini V, Montanaro L,
Arciola CR. The presence of both bone sialoprotein-binding protein gene
and collagen adhesin gene as a typical virulence trait of the major
epidemic cluster in isolates from orthopedic implant infections. Biomaterials.
2009;30(34):6621–8.
58. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain
USA300: origin and epidemiology. J Antimicrob Chemother. 2009;64(3):441–6.
59. Belthur MV, Birchansky SB, Verdugo AA, Mason EO Jr, Hulten KG, Kaplan SL,
Smith EO, Phillips WA, Weinberg J. Pathologic fractures in children with
acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am. 2012;
94(1):34–42.
60. Gonzalez BE, Teruya J, Mahoney DH Jr, Hulten KG, Edwards R, Lamberth LB,
Hammerman WA, Mason EO Jr, Kaplan SL. Venous thrombosis associated
with staphylococcal osteomyelitis in children. Pediatrics. 2006;117(5):1673–9.
61. Olson ME, Horswill AR. Staphylococcus aureus osteomyelitis: bad to the
bone. Cell Host Microbe. 2013;13(6):629–31.
62. Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, Kim N. The mechanism of
osteoclast differentiation induced by IL-1. J Immunol. 2009;183(3):1862–70.
63. Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y. IL-1 plays an important
role in the bone metabolism under physiological conditions. Int Immunol.
2010;22(10):805–16.
64. Marriott I, Gray DL, Tranguch SL, Fowler VG Jr, Stryjewski M, Scott Levin L,
Hudson MC, Bost KL. Osteoblasts express the inflammatory cytokine
interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and
infected human bone tissue. Am J Pathol. 2004;164(4):1399–406.
65. Ono T, Okamoto K, Nakashima T, Nitta T, Hori S, Iwakura Y, Takayanagi H. IL-
17-producing gammadelta T cells enhance bone regeneration. Nat
Commun. 2016;7:10928.
66. Lee Y. The role of interleukin-17 in bone metabolism and inflammatory
skeletal diseases. BMB Rep. 2013;46(10):479–83.
67. Wright JA, Nair SP. Interaction of staphylococci with bone. Int J Med
Microbiol. 2010;300(2–3):193–204.
68. Komnenou A, Karayannopoulou M, Polizopoulou ZS, Constantinidis TC, Dessiris
A. Correlation of serum alkaline phosphatase activity with the healing process
of long bone fractures in dogs. Vet Clin Pathol. 2005;34(1):35–8.
69. Nakagawa H, Kamimura M, Takahara K, Hashidate H, Kawaguchi A,
Uchiyama S, Miyasaka T. Changes in total alkaline phosphatase level after
hip fracture: comparison between femoral neck and trochanter fractures. J
Orthop Sci. 2006;11(2):135–9.
70. Xu L, Lv K, Zhang W, Zhang X, Jiang X, Zhang F. The healing of critical-size
calvarial bone defects in rat with rhPDGF-BB, BMSCs, and beta-TCP scaffolds.
J Mater Sci Mater Med. 2012;23(4):1073–84.
71. Ahmed S, Meghji S, Williams RJ, Henderson B, Brock JH, Nair SP.
Staphylococcus aureus fibronectin binding proteins are essential for
internalization by osteoblasts but do not account for differences in
intracellular levels of bacteria. Infect Immun. 2001;69(5):2872–7.
72. Elasri MO, Thomas JR, Skinner RA, Blevins JS, Beenken KE, Nelson CL,
Smeltzer MS. Staphylococcus aureus collagen adhesin contributes to the
pathogenesis of osteomyelitis. Bone. 2002;30(1):275–80.
73. Loughran AJ, Gaddy D, Beenken KE, Meeker DG, Morello R, Zhao H, Byrum
SD, Tackett AJ, Cassat JE, Smeltzer MS. Impact of sarA and phenol-soluble
modulins on the pathogenesis of osteomyelitis in diverse clinical isolates of
Staphylococcus aureus. Infect Immun. 2016;84(9):2586–94.
74. Kavanagh N, Ryan EJ, Widaa A, Sexton G, Fennell J, O'Rourke S, Cahill KC,
Kearney CJ, O'Brien FJ, Kerrigan SW. Staphylococcal osteomyelitis: disease
progression, treatment challenges, and future directions. Clin Microbiol Rev.
2018;31(2):e00084–17.
75. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its
production and regulation. Int J Artif Organs. 2005;28(11):1062–8.
76. Costerton JW, Montanaro L, Arciola CR. Bacterial communications in implant
infections: a target for an intelligence war. Int J Artif Organs. 2007;30(9):757–
63.
77. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of
microorganisms to host tissues. Annu Rev Microbiol. 1994;48:585–617.
78. Patti JM, Hook M. Microbial adhesins recognizing extracellular matrix
macromolecules. Curr Opin Cell Biol. 1994;6(5):752–8.
79. Speziale P, Pietrocola G, Rindi S, Provenzano M, Provenza G, Di Poto A, Visai
L, Arciola CR. Structural and functional role of Staphylococcus aureus
surface components recognizing adhesive matrix molecules of the host.
Future Microbiol. 2009;4(10):1337–52.
80. Josse J, Velard F, Gangloff SC. Staphylococcus aureus vs. osteoblast:
relationship and consequences in osteomyelitis. Front Cell Infect Microbiol.
2015;5:85.
81. Post V, Wahl P, Uckay I, Ochsner P, Zimmerli W, Corvec S, Loiez C, Richards
RG, Moriarty TF. Phenotypic and genotypic characterisation of
Staphylococcus aureus causing musculoskeletal infections. Int J Med
Microbiol. 2014;304(5–6):565–76.
82. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long
D, Bubeck Wardenburg J, Schneewind O, Otto M, Deleo FR. Comparative
analysis of USA300 virulence determinants in a rabbit model of skin and
soft tissue infection. J Infect Dis. 2011;204(6):937–41.
83. Li M, Cheung GY, Hu J, Wang D, Joo HS, Deleo FR, Otto M. Comparative
analysis of virulence and toxin expression of global community-associated
methicillin-resistant Staphylococcus aureus strains. J Infect Dis. 2010;202(12):
1866–76.
84. Rom JS, Ramirez AM, Beenken KE, Sahukhal GS, Elasri MO, Smeltzer MS. The
impacts of msaABCR on sarA-associated phenotypes are different in
divergent clinical isolates of Staphylococcus aureus. Infect Immun. 2020;
88(2):e00530–19.
85. Tucci M, Wilson GA, McGuire R, Benghuzzi HA. The effects of NPY1 receptor
antagonism on intervertebral disc and bone changes in ovariectomized rats.
Global Spine J. 2020:2192568220939908.
86. Doube M, Klosowski MM, Arganda-Carreras I, Cordelieres FP, Dougherty RP,
Jackson JS, Schmid B, Hutchinson JR, Shefelbine SJ. BoneJ: free and
extensible bone image analysis in ImageJ. Bone. 2010;47(6):1076–9.
87. Franco M, D'Haeseleer PM, Branda SS, Liou MJ, Haider Y, Segelke BW, El-Etr
SH. Proteomic profiling of Burkholderia thailandensis during host infection
using bio-orthogonal noncanonical amino acid tagging (BONCAT). Front
Cell Infect Microbiol. 2018;8:370.
Sahukhal et al. BMC Microbiology          (2020) 20:324 Page 19 of 20
88. Fruzangohar M, Ebrahimie E, Adelson DL. A novel hypothesis-unbiased
method for gene ontology enrichment based on transcriptome data. PLoS
One. 2017;12(2):e0170486.
89. Fruzangohar M, Ebrahimie E, Ogunniyi AD, Mahdi LK, Paton JC, Adelson DL.
Comparative GO: a web application for comparative gene ontology and
gene ontology-based gene selection in bacteria. PLoS One. 2013;8(3):
e58759.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Sahukhal et al. BMC Microbiology          (2020) 20:324 Page 20 of 20
